Notícias e Atividades da Frontier Medicines
Presença
Fusão, aquisição e financiamento envolvendo Frontier Medicines.
- Frontier Medicines acaba de anunciar uma arrecadação de fundos de 80 milhões de dólares. (publicado em 27 de fevereiro de 2024).
Executivos
Veja o organograma con seus 17 executivos principais
Biografias mais buscadas da Frontier Medicines
- Chris Varma, Chairman and Chief Executive Officer
- Cameron Wheeler, Director
- Sisi Pouraghabagher, Director
Criar um alerta
para seguir os movimentos de executivos da Frontier Medicines.
Farmacêutica
Frontier Medicines possui 1.834 concorrentes concorrentes Pfizer (Estados Unidos), Eli Lilly (Estados Unidos) e Sanofi (França).
Popular M&A news in Farmacêutica
- Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).
- Knight Therapeutics has announced the acquisition of Paladin Labs (publicado em 12 de março de 2025).
- Jazz Pharmaceuticals adquiriu Chimerix (publicado em 6 de março de 2025).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Frontier Medicines
- Frontier Medicines to Participate in Two Upcoming March Investor Conferences | Frontier Medicine
- Frontier Medicines to Participate in Two Upcoming March Investor Conferences | Frontier Medicine
- Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference | Frontier Medicine
- Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential | Frontier Medicine
- Frontier Medicines Announces Milestone Payment in AbbVie Partnership, Following Advancement of Lead Candidates Targeting a Historically Undruggable Transcription Factor | Frontier Medicine
- Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting | Frontier Medicine
- Frontier Medicines to Present Preclinical Data at the American Association of Cancer Research Annual Meeting 2024 | Frontier Medicine
- Frontier gets $80M, Galapagos’ backing to make a better KRAS drug
- Frontier Medicines to Participate in Upcoming Investor Conferences | Frontier Medicine
- Frontier Medicines Announces Oversubscribed $80 Million Series C Financing to Support Progress of Clinical-Stage Pipeline | Frontier Medicine
- View more press releases Close
Redes sociais sobre Frontier Medicines
- Frontier Medicines na Wikipedia, Google News e Yahoo Finance
- Frontier Medicines na LinkedIn, Twitter e YouTube
